Myomo (MYO) Non-Current Debt (2017 - 2025)
Myomo's (MYO) quarterly Non-Current Debt came in at $11.2 million in Q4 2025, little changed YoY from $11.2 million in Q4 2024, and up 364.36% on a QoQ basis from $2.4 million in Q3 2025.
Myomo (MYO) Non-Current Debt (2017 - 2025) Analysis & Trends
Myomo (MYO) has 5 years of Non-Current Debt data on file, last reported at $11.2 million in Q4 2025.
- Quarterly Non-Current Debt changed 0.0% year-over-year to $11.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.2 million (changed 0.0% YoY) and the FY2025 annual result came in at $11.2 million, changed 0.0% from the prior year.
- Non-Current Debt grew to $11.2 million in Q4 2025, from $2.4 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $11.2 million in Q4 2024 to a low of $1.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Myomo | 67.26 Mn | 48.29 Mn | - | 11.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.22 Mn |
| Sep 30, 2025 | 2.42 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Dec 31, 2024 | 11.22 Mn |
| Jun 30, 2020 | 77,892.00 |
| Dec 31, 2019 | 888,961.00 |
| Dec 31, 2017 | 750,000.00 |
| Sep 30, 2017 | 876,458.00 |
| Jun 30, 2017 | 876,458.00 |